Sinofuture Pharmaceutical Co., Ltd.
Sinofuture Pharmaceutical Co., Ltd., was established with investment from leading Chinese pharmaceutical R&D institutions and manufacturers.
We are committed to building an open platform and becoming a professional enterprise serving the global pharmaceutical supply chain. By partnering with pharmaceutical companies in a business representative role, we aim to foster strong, long-term relationships with our customers.
Supported by an excellent technical team and GMP compliance specialists, we connect qualified manufacturing facilities with world-class API and FDF customers. Through deep collaboration between technology-driven factories and global partn
Development history
- The company was officially established in October 2020
- Obtained a drug production license in March 2022。
- Obtained the GMP certificate of veterinary medicine in May 2023
- An intermediate foreign trade order was completed in May 2023
Culture
At Sinofuture Pharma, our corporate culture is rooted in integrity, innovation, collaboration and excellence. We are committed to advancing pharmaceutical science through continuous innovation, delivering high-quality products with uncompromising responsibility, and fostering long-term partnerships built on trust. Guided by a global vision, we embrace diversity, encourage teamwork, and strive to create sustainable value for our customers, employees, and society.
Integrity
Innovation
Collaboration
Excellence
Our Vision
To be a global leader in the pharmaceutical industry, delivering high-quality APIs that improve health and well-being worldwide.
Our Mission
To manufacture and supply high-quality APIs through innovation, excellence, and a commitment to customer satisfaction. We aim to achieve this by:
Copyright © 2025 Sinofuture Pharma
粤20250816100586